Ian D Davis

33PUBLICATIONS
238CO-AUTHORS
Predictive and prognostic markersMolecular targetsPharmacogenomicsPacific Peoples community governance and decision makingRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Jul 08, 2026
Development and Validation of a Computational Histology Artificial Intelligence-Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials.

|Jul 02, 2026
Germline CDK12 variants in aggressive prostate cancer.

|Jun 26, 2026
AI-Based Pathology classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET Trial.

|Apr 28, 2026
177Lu-PSMA-617 SPECT/CT for Early Prediction of Overall Survival in Participants with Metastatic Castration-Resistant Prostate Cancer.

|Apr 15, 2026
Predictive value of early PSMA upregulation for the response to enzalutamide ± 177Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer: substudy of the randomized, phase 2 ENZA-p trial.

|Mar 02, 2026
Management of Advanced Prostate Cancer in the Asia-Pacific Region: Summary of the Asia-Pacific Advanced Prostate Cancer Symposium 2025.

Edmund Chiong, Renu Eapen, Nicholas Buchan

Pageof 6

Frequent Collaborators

11 joint publications

Martin R Stockler

7 joint publications

Anthony M Joshua

5 joint publications

Shahneen Sandhu

5 joint publications

Michael S Hofman